Lipocine Inc (LPCN)
4.67
-0.23
(-4.66%)
USD |
NASDAQ |
Dec 26, 16:00
4.67
0.00 (0.00%)
After-Hours: 20:00
Lipocine Cash from Financing (Quarterly): 0.00 for Sept. 30, 2024
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Pfizer Inc | -4.636B |
| Reviva Pharmaceuticals Holdings Inc | 3.622M |
| NovaBay Pharmaceuticals Inc | 2.089M |
| Palatin Technologies Inc | -0.127M |
| iBio Inc | -0.162M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.833M |
| Cash from Investing (Quarterly) | 1.022M |
| Free Cash Flow | -5.035M |
| Free Cash Flow Per Share (Quarterly) | -0.5447 |
| Free Cash Flow Yield | -20.18% |